drugset / Trial / NCT03527069
Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of Cipros 10 association in the treatment of Dyslipidemia Treatment
Timeline
- Start
- 2021-01-29
- Primary completion
- 2024-08-30
- Completion
- 2025-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cipros 10 association | Unknown | — | Oral |
| Comparator | Rosuvastatin | Small molecule | 10 mg | Oral |